The Curies’ element: state of the art and perspectives on the use of radium in nuclear medicine
Abstract Background The alpha-emitter radium-223 (223Ra) is presently used in nuclear medicine for the palliative treatment of bone metastases from castration-resistant prostate cancer. This application arises from its advantageous decay properties and its intrinsic ability to accumulate in regions...
שמור ב:
| Principais autores: | , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
SpringerOpen
2023-11-01
|
| סדרה: | EJNMMI Radiopharmacy and Chemistry |
| נושאים: | |
| גישה מקוונת: | https://doi.org/10.1186/s41181-023-00220-4 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|